Mode of stabilizing action of non-steroid anti-inflammatory drugs on erythrocyte membrane.
D000632:Aminopyrine / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects; D002462:Cell Membrane / Q000187:drug effects*; D004285:Dogs; D004912:Erythrocytes / Q000187:drug effects*; D005439:Flufenamic Acid / Q000494:pharmacology; D006461:Hemolysis / Q000187:drug effects; D006358:Hot Temperature; D006863:Hydrogen-Ion Concentration; D007213:Indomethacin / Q000494:pharmacology; D008244:Lysophosphatidylcholines / Q000494:pharmacology; D009578:Nitrobenzenes / Q000494:pharmacology; D010113:Oxyphenbutazone / Q000494:pharmacology; D010653:Phenylbutazone / Q000494:pharmacology; D010740:Phospholipases / Q000494:pharmacology; D011489:Protein Denaturation / Q000187:drug effects; D011720:Pyrazoles / Q000494:pharmacology; D012459:Salicylates / Q000494:pharmacology; D012503:Saponins / Q000494:pharmacology; D012710:Serum Albumin, Bovine; D013431:Sulfates / Q000494:pharmacology; D013501:Surface-Active Agents / Q000494:pharmacology; D062367:ortho-Aminobenzoates / Q000494:pharmacology
D000893:Anti-Inflammatory Agents; D008244:Lysophosphatidylcholines; D009578:Nitrobenzenes; D011720:Pyrazoles; D012459:Salicylates; D012503:Saponins; D013431:Sulfates; D013501:Surface-Active Agents; D062367:ortho-Aminobenzoates; D000632:Aminopyrine; D012710:Serum Albumin, Bovine; D005439:Flufenamic Acid; D010740:Phospholipases; D010653:Phenylbutazone; D010113:Oxyphenbutazone; D001241:Aspirin; D007213:Indomethacin